Posted by Michael Wonder on 04 Mar 2022
Approved first generic for Apokyn injection cartridges requires separately packaged pen
24 February 2022 - The U.S. FDA has approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) associated with advanced Parkinson’s disease.
Prescribers and pharmacists should be aware that patients starting treatment with generic apomorphine hydrochloride injection will need to separately obtain the Apokyn Pen.
